The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HRQoL) of pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase III KEYNOTE-590 study.
 
Wasat Mansoor
Honoraria - Bristol-Myers Squibb; Servier
Consulting or Advisory Role - Bristol-Myers Squibb; SERVIER
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; SERVIER; SERVIER
 
Amit S. Kulkarni
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ken Kato
Honoraria - Bristol-Myers Squibb; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Research Funding - Beigene (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Jong-Mu Sun
Research Funding - AstraZeneca/MedImmune (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst)
 
Manish A. Shah
Consulting or Advisory Role - Astellas Pharma; Lilly Japan
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Oncolys BioPharma (Inst)
 
Peter C. Enzinger
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; loxo; Merck; Taiho Pharmaceutical; Takeda; Zymeworks
 
Antoine Adenis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Merck Serono
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Toshihiko Doi
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb Japan; Oncolys BioPharma; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Boehringer Ingelheim; Daiichi Sankyo; MSD; Novartis; Otsuka; Rakuten Medical; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst)
 
Takashi Kojima
Honoraria - Oncolys BioPharma; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Merck; MSD; Ono Pharmaceutical
Research Funding - Astellas Amgen BioPharama (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Jean-Philippe Metges
Honoraria - Bristol-Myers Squibb; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
Zhigang Li
No Relationships to Disclose
 
Sung-Bae Kim
Honoraria - DAEHWA Pharmaceutical; ISU ABXIS
Consulting or Advisory Role - AstraZeneca; DAEHWA Pharmaceutical; ISU Abxis; Lilly (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Byoung Chul Cho
Leadership - Gencurix; Interpark Bio
Stock and Other Ownership Interests - Bridgebio; Cyrus Therapeutics; Gencurix; Interpark Bio; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - AstraZeneca; Blueprint medicines; Boehringer Ingelheim; Bridgebio; Bridgebio; Bristol-Myers Squibb; Cyrus Therapeutics; Guardant Health; Janssen; Kanaph Therapeutics; Lilly; medpacto; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda; Yuhan
Research Funding - Abbvie; AstraZeneca; Bayer; Blueprint medicines; Champions Oncology; Dizal Pharma; Dong-A ST; GI Innovation; Interpark Bio; Janssen; Lilly; medpacto; Mogam Biotechnology Research Institue; MSD; Novartis; Ono Pharmaceutical; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology
Other Relationship - Champions Oncology; DAAN Biotherapeutics
 
Patrapim Sunpaweravong
No Relationships to Disclose
 
MARIA ALSINA
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD Oncology; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Roche/Genentech
 
Eray Goekkurt
Honoraria - Bristol-Myers Squibb; MSD; SERVIER
 
Shailaja Suryawanshi
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Josephine Norquist
Employment - Merck (I)
Stock and Other Ownership Interests - Merck
 
Sukrut Shah
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Lin Shen
No Relationships to Disclose